@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-P19FH0G9-K
  skos:prefLabel "Phentermine"@fr, "Phentermine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-RJQR66VQ-7 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-RJQR66VQ-7
  mesh:allowableQualifier jvr:-M63HSDM7-1, jvr:-WK5F724J-1, jvr:-Q3979798-W, jvr:-G4R176S9-J, jvr:-BT300B3G-Q, jvr:-R0ZCQ8X6-J, jvr:-H7K65Q8S-Z, jvr:-R3QWLHRG-V, jvr:-S0CS1X5R-5, jvr:-NFTHND7Q-8, jvr:-SBNWSM1T-R, jvr:-D0F21513-5, jvr:-CB30NGKB-3, jvr:-L6C0XPHT-4, jvr:-NB0XHT3S-N, jvr:-G30ZJ446-J, jvr:-W6SQV79N-S, jvr:-TJHVZCRZ-0, jvr:-NKM836P1-M, jvr:-T9HQD7ST-J, jvr:-NHL3D2X0-S, jvr:-HQRFT0C6-B, jvr:-XV06LPML-W, jvr:-FWD2BGQ0-9, jvr:-THHNVC7V-3 ;
  skos:altLabel "100-92-5 (Mephentermine)"@fr, "100-92-5 (Mephentermine)"@en, "Benzeneethanamine, N,alpha,alpha-trimethyl-"@fr, "Benzeneethanamine, N,alpha,alpha-trimethyl-"@en, "1212-72-2 (Mephentermine Sulfate)"@fr, "1212-72-2 (Mephentermine Sulfate)"@en, "580655Z8RR"@en, "580655Z8RR"@fr, "TEZ91L71V4"@fr, "TEZ91L71V4"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D008616> ;
  dc:modified "2013-07-08"^^xsd:date ;
  skos:prefLabel "Mephentermine"@en, "Méphentermine"@fr ;
  dc:established "1966-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:broader jvr:-P19FH0G9-K ;
  mesh:pharmacologicalAction jvr:-QN6MCZ3D-Q, jvr:-R9SB4WRS-X, jvr:-PF128B09-N ;
  dc:created "1999-01-01"^^xsd:date ;
  a mesh:Descriptor, skos:Concept ;
  skos:hiddenLabel "Mephentermine Sulfate"@en, "Mephentermine Sulfate (2:1)"@en, "Sulfate de méphentermine"@fr ;
  skos:definition "A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA."@en .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R9SB4WRS-X
  skos:prefLabel "Vasoconstricteurs"@fr, "Vasoconstrictor Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-QN6MCZ3D-Q
  skos:prefLabel "Agonistes des récepteurs alpha-1 adrénergiques"@fr, "Adrenergic alpha-1 Receptor Agonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PF128B09-N
  skos:prefLabel "Sympathomimétiques"@fr, "Sympathomimetics"@en ;
  a mesh:Descriptor, skos:Concept .